FOLH1 and posterior cortical atrophy: [68Ga]Ga-PSMA-11 was the first PSMA PET radiotracer approved for primary staging of patients with high-risk PCa and restaging of patients with biochemical recurrence of PCa (3), followed by 18F-labeled PET radiotracers, including [18F]DCFPyL (4–6), [18F]rhPSMA-7.3 (7,8), and [18F]PSMA-1007 (9,10).